tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

FISFidelity National Information Services

Financials · Business Services · NYSE
Compare with peers → Embed
Planned sales, announced before they happen

1 trading plan running, 1 Form 144 notice for $944K

10-Q, 10-K and Form 144
Plans running now
1
Mr. Jeffrey Goldstein
Plans adoptedList ↓
5
reported since May 2, 2023
Form 144 noticesList ↓
1
$944K the sellers expected to sell

What FIS's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Trading plans

Plans adopted or ended

XBRL, 10-Q and 10-K
InsiderWhatDateSharesRuns toReported in
Mr. Jeffrey Goldstein
Independent Chair of the Company’s Board of Directors
Adopted 10b5-1 plan Dec 3, 2025 up to 225,000 Jan 22, 2027 10-K Feb 24, 2026
What the company wrote
During the quarter ended December 31, 2025, Mr. Jeffrey Goldstein, Independent Chair of the Company’s Board of Directors, adopted a trading plan intended to satisfy the affirmative defense of Rule 10b5-1(c). Under the plan, which was adopted on December 3, 2025, Mr. Goldstein instructed his broker to purchase shares of FIS common stock each quarter in an amount approximately equal to his cash director fees, which are paid quarterly in equal installments. The aggregate purchase price for shares to be purchased under the plan is $225,000. The trading plan will expire on the earlier of January 22, 2027 or the date on which all purchases under the plan have been completed. Mr. Goldstein has informed the Company that he intends to continue to use the full amount of his cash director fees to purchase FIS common stock for so long as he remains a Director of the Company.
Ms. Caroline Tsai
Chief Legal & Corporate Affairs Officer and Corporate Secretary
Adopted 10b5-1 plan May 29, 2025 up to 500,000 May 29, 2026 10-Q Aug 5, 2025
Mr. Jeffrey Goldstein
Independent Chair of the Company’s Board of Directors
Adopted 10b5-1 plan Nov 18, 2024 up to 241,000 438 days 10-K Feb 13, 2025
What the company wrote
During the quarter ended December 31, 2024, Mr. Jeffrey Goldstein, Independent Chair of the Company’s Board of Directors, adopted a trading plan intended to satisfy the affirmative defense of Rule 10b5-1(c). Under the plan, which was adopted on November 18, 2024, Mr. Goldstein instructed his broker to purchase shares of FIS common stock each quarter in an amount approximately equal to his cash director fees, which are paid quarterly in equal installments. The aggregate purchase price for shares to be purchased under the plan is $241,000. The trading plan will expire on the earlier of January 30, 2026 or the date on which all purchases under the plan have been completed. Mr. Goldstein has informed the Company that he intends to continue to use the full amount of his cash director fees to purchase FIS common stock for so long as he remains a Director of the Company.
Ms. Denise Williams
executive officer of the Company (Chief People Officer)
Adopted 10b5-1 plan Aug 14, 2024 up to 12,484 Mar 31, 2025 10-Q Nov 4, 2024
What the company wrote
During the quarter ended September 30, 2024, Ms. Denise Williams, an executive officer of the Company (Chief People Officer), adopted a trading plan (the “Plan”) intended to satisfy the affirmative defense of Rule 10b5-1(c). The Plan, which was adopted on August 14, 2024, provides for the sale of up to $1,000,000 of shares of FIS common stock and up to 12,484 shares of FIS common stock to be acquired through the exercise of vested stock options. The Plan will expire on the earlier of March 31, 2025, or the date on which all sales under the Plan have been completed.
Mr. Jeffrey Goldstein
Independent Chair of the Company’s Board of Directors
Adopted 10b5-1 plan Nov 16, 2023 up to 220,000 442 days 10-K Feb 26, 2024
What the company wrote
During the quarter ended December 31, 2023, Mr. Jeffrey Goldstein, Independent Chair of the Company’s Board of Directors, adopted a trading plan intended to satisfy the affirmative defense of Rule 10b5-1(c). Under the plan, which was adopted on November 16, 2023, Mr. Goldstein instructed his broker to purchase shares of FIS common stock each quarter in an amount approximately equal to his cash director fees, which are paid quarterly in equal installments. The aggregate purchase price for shares to be purchased under the plan is $220,000. The trading plan will expire on the earlier of January 31, 2025 or the date on which all purchases under the plan have been completed. Mr. Goldstein has informed the Company that he intends to continue to use the full amount of his cash director fees to purchase FIS common stock for so long as he remains a Director of the Company.

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 2, 2023.

Form 144

Notices of planned sales

Form 144 XML, SEC
FiledSellerSharesValueShares came from10b5-1 planForm 4 sales after
Aug 11, 2026 Tsai Caroline
Former Officer
22,142 $944K Restricted Stock Vesting none given none found

From the Form 144 XML filed with the SEC, since Aug 11, 2026. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Next Owners →